Clinical trial · Interventional
Study of Patient Navigation to Promote Colon Cancer Screening
Randomized Controlled Trial of Patient Navigation to Increase Colorectal Cancer Screening Rates Among Community Health Center Patients
NCT01141114CI-TRIAL-00027053completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will investigate whether patient navigation can increase rates of colorectal cancer screening among linguistically and culturally diverse disadvantaged patients served by urban community health centers.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer Screening | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patient navigation | Other | — | UNRESOLVED |
| Usual care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Use of a Patient Navigator
- interventionNames
- Other: Patient navigation
- type
- OTHER
- label
- Usual Care
- description
- No Intervention - usual care
- interventionNames
- Other: Usual care
Primary outcomes (1)
- measure
- completion of colorectal cancer screening
- timeFrame
- 1 year
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 52 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Patients aged 52-75 who had one visit to a primary care physician in a community health center in each of the 2 previous years and who have not received colorectal cancer screening based on HEDIS criteria. Exclusion Criteria: * Current cancer diagnosis, undergoing treatment (or treatment completed within the past year) * Severe cardiac disease (high-risk CAD,9 valvular disease, NYHA Class III or IV CHF, EF \< 35%) * Severe COPD (FEV1\< 1liter or on home oxygen) * CVA with severe functional impairment (aphasia or hemiparesis) * MS with severe functional impairment * Renal failure with CrCl\< 30 or on dialysis * Gastrointestinal symptoms (pain, bleeding, etc) within the past 6 months * Chronic active liver disease or cirrhosis, with albumin \< 3 or elevated INR * Advanced HIV disease (CD4 count \<200) * Severe lupus (with cerebritis or renal failure as defined above) * Severe complications of diabetes (blindness, amputations other than toes) * Advanced Dementia * Psychosis * Paranoia * Active substance abuse * Schizophrenia * Psychiatric hospitalization within the past year
References
Publications (2)
- BACKGROUNDLasser KE, Ayanian JZ, Fletcher RH, Good MJ. Barriers to colorectal cancer screening in community health centers: a qualitative study. BMC Fam Pract. 2008 Feb 27;9:15. doi: 10.1186/1471-2296-9-15. PMID 18304342
- DERIVEDLasser KE, Murillo J, Lisboa S, Casimir AN, Valley-Shah L, Emmons KM, Fletcher RH, Ayanian JZ. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med. 2011 May 23;171(10):906-12. doi: 10.1001/archinternmed.2011.201. PMID 21606094